PAYX vs UPB · P/E 22, rev $6.51B vs rev $2.9M
Paychex Inc (PAYX) versus Upstream Bio, Inc. (UPB) — a side-by-side from cached financials, not a winner call.
Paychex Inc (PAYX) is a software - application company listed on NASDAQ.
Upstream Bio, Inc. (UPB) is a biotechnology company listed on US.
Latest reported PAYX revenue for 2026-05-31 was $6.51B. Net income was $1.76B. Revenue was up 16.9% from 2025-05-31 to 2026-05-31. PAYX currently screens at market cap $34.96B and trailing P/E 21.5.
Latest reported UPB revenue for 2025-12-31 was $2.9M. Net income was -$143.4M. Revenue was up 20.4% from 2024-12-31 to 2025-12-31. UPB currently screens at market cap $407.3M.
PAYX currently screens at market cap $34.96B and trailing P/E 21.5. UPB currently screens at market cap $407.3M.
Not investment advice. Open the PAYX and UPB stock pages for the full models.
Not investment advice.